Protocol Status: PUBLISHED
Protocol:
Version: 2026.01
Effective Date:
Last Reviewed:
Medical Director Approval:
Clinical Note: This content reflects current GCEMS clinical guidelines as of the dates listed above. If content appears inconsistent with current policy, use the most recent approved guideline and notify leadership for correction.

Dextrose 10%

(D10)

 

Indications:

 

  • Suspected hypoglycemia
  • Altered LOC
  • Coma/seizure or unknown etiology

 

Contraindications:

 

  • Intracranial hemorrhage
  • Known CVA

 

Side Effects:

 

  • Local irritation may precipitate severe neurologic symptoms in alcoholics.

 

Adult Dose:

 

  • 250 mL IV; may repeat once if still unresponsive and low BGL

 

Pediatric Dose:

 

  • 5 mL IV; may repeat once if still unresponsive and low BGL